EH
EHTH.O
—
NASDAQ
Multiline Insurance & Brokers
eHealth Inc
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
44,5M USD
P/E
—
EV / Rev
—
Div yield
—
Op margin
12,0 %
ROE
4,1 %
Net margin
7,2 %
Debt / equity
0,12
Beta
—
52w range
—
Volume
3,3k
Day range
$1,51–$1,58
Prev close
$1,59
Open
$1,58
Next earnings
2026-10-28
Ex-dividend
—
TR 1Y
—
About
eHealth Inc provides online health insurance and related services to individuals and small businesses in the United States, generating revenue primarily through commissions and fees from insurance carriers and policyholders.
Business. eHealth Inc (EHTH.O) is a multiline insurance and broker headquartered in the United States, operating within the Financials sector. The company is primarily listed on the NASDAQ exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
Classification92 %
SectorFinancials
Business sectorInsurance
IndustryMultiline Insurance & Brokers
ActivityAsset Management
Generated · model-assisted
Sell-side consensus
HOLD5 analysts
0 buy5 hold0 sell
Avg 12m price target2,25
Analyst recommendations
5 analysts · consensus HoldBuy0
Hold5
Sell0
12-month price target
2,25
Consensus of sell-side coverage.
At a glance
Score
—
not yet scored
Valuation
—
valuation pending
Analysts→
Hold
5 analysts · indicative
Ownership→
AQR Capital Management, LLC
largest disclosed fund holder
Profitability→
4,1 %
return on equity
Quality
—
not yet scored
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
— missing data
News & coverage
0Sector rotation
Sector1D1Mvs mkt
Materials+2,3 %+6,6 %+1,7 %
Communication Services+2,2 %−5,5 %+1,6 %
Energy+0,6 %+3,3 %+0,0 %
Health Care+0,6 %−0,8 %+0,0 %
Information Technology+0,6 %+6,7 %+0,0 %
Consumer Discretionary+0,4 %+7,6 %−0,2 %
Financials · THIS SECTOR−0,3 %−2,8 %−0,9 %
Consumer Staples−0,4 %+2,5 %−1,0 %
Real Estate−0,7 %+10,9 %−1,3 %
Industrials−1,9 %−3,1 %−2,5 %
Utilities−1,9 %+28,2 %−2,5 %
Developing storylines
No tracked sagas currently linked to EHTH.O. Browse all sagas →
Analysis
AI analysis
Generated · analysis pipeline · tier hybrid · as of 2026-08-04
↑ At a glance
Opportunity
— missing data
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
— missing data
Signals & dispatch
peak dispatch · —
Composite-score breakdown
Synthesis
Business
eHealth Inc (EHTH.O) is a multiline insurance and broker headquartered in the United States, operating within the Financials sector. The company is primarily listed on the NASDAQ exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
Classification92 %
SectorFinancials
Business sectorInsurance
IndustryMultiline Insurance & Brokers
ActivityAsset Management
AI synthesis
GENERATEDeHealth Inc maintains a low debt-to-equity ratio of 0.12, indicating a conservative capital structure with limited leverage. The company's liquidity position is characterized as medium, with a current ratio of 3.37, suggesting it can cover short-term obligations but may face constraints in capital-intensive operations. Despite a negative net cash position after subtracting total debt, the company's free cash flow of $14.89 million provides some flexibility for operational needs.
Profitability metrics show a return on equity (ROE) of 4.11% and a return on assets (ROA) of 3.17%, both below the industry median for multiline insurance and brokers, which typically exceeds 6% ROE and 4% ROA. The company's operating margin of 12.0% is in line with industry norms, but its net margin of 7.22% is lower than the median, indicating higher cost pressures or lower pricing power.
Geographically, eHealth Inc is concentrated in the U.S., with all revenue derived from domestic operations. The company operates through a single business segment focused on health insurance services, with no material diversification across product lines or geographic regions.
The company's revenue growth is expected to remain flat in the current fiscal year, with a projected increase of less than 1% year-over-year. This aligns with the broader industry trend of moderate growth in the insurance sector, driven by regulatory stability and a saturated market.
Risk factors include a medium liquidity risk due to negative net cash and a low dilution risk, with no significant dilution sources identified in recent filings. The company's operating cash flow is negative at -$25.35 million, which could pressure liquidity if free cash flow does not improve.
Recent events include a 10-K filing disclosing continued reliance on a narrow customer base and regulatory compliance challenges in the health insurance market. Analysts have issued a mean price target of $2.25, with a median of $2.00, reflecting cautious optimism about the company's ability to stabilize its cash flow and improve margins.
Key takeaways
- eHealth Inc has a conservative capital structure with a low debt-to-equity ratio of 0.12.
- The company's ROE of 4.11% and ROA of 3.17% lag behind industry medians, indicating weaker profitability.
- Revenue is entirely U.S.-based, with no diversification across geographic regions or business segments.
- Analysts project a mean price target of $2.25, suggesting limited upside potential in the near term.
- Liquidity risk is moderate, with a current ratio of 3.37 but negative net cash after debt.
Bull / Bear case
Generated · model-assisted— missing data
In focus — financials by report
Valuation
Market price
$1,41
Market cap
$56.1M
Enterprise valueⓘ
$153.5M
P/Eⓘ
—
Non-GAAP P/Eⓘ
—
EV / Revenueⓘ
—
EV / Op incomeⓘ
—
EV / OCFⓘ
—
P / Bⓘ
0.1x
P / Tangible bookⓘ
0.1x
Tangible book
$973.7M
Net cashⓘ
-$97.4M
Current ratioⓘ
3.4
Debt / equityⓘ
0.1
ROAⓘ
3.2%
ROEⓘ
4.1%
Cash conversionⓘ
-63.0%
CapEx / revenueⓘ
-2.8%
SBC / revenueⓘ
—
Dilution ratioⓘ
0.0%
Revenue by segment
Business relationships
Business relationships5 disclosed relationships · 1 type · extracted from filings & disclosures
Subsidiaries5
EX21:6e246852e8abEX21:6e246852e8abSubsidiarie97%
EX21:a79808c3a11dEX21:a79808c3a11dSubsidiarie97%
EX21:cf4f5c5ee91fEX21:cf4f5c5ee91fSubsidiarie97%
EX21:d30e4f264aceEX21:d30e4f264aceSubsidiarie97%
EX21:ec356e068512EX21:ec356e068512Subsidiarie97%
Supply chain
— missing data
Peer comparison
Peer comparison8 peers · vs EHTH · multiples and returns
CB
CB—
Chubb Ltd
$348,23
137,4B USDP/E
13,2x
+11,8 vs self
Div yield
1,1 %
— vs self
ROE
14,0 %
+9,9 vs self
MR
MRSH—
MARSH & MCLENNAN COMPANIES, INC.
$192,84
93,3B USDP/E
20,7x
+19,3 vs self
Div yield
1,9 %
— vs self
ROE
27,0 %
+22,9 vs self
AO
AON—
Aon PLC
$357,63
76,7B USDP/E
21,3x
+19,9 vs self
Div yield
0,8 %
— vs self
ROE
38,5 %
+34,4 vs self
AJ
AJG—
Arthur J Gallagher & Co
$247,79
63,7B USDP/E
41,6x
+40,2 vs self
Div yield
1,1 %
— vs self
ROE
6,3 %
+2,2 vs self
WT
WTW—
WILLIS TOWERS WATSON
$341,28
32,1B USDP/E
165,4x
+164,0 vs self
Div yield
1,5 %
— vs self
ROE
1,5 %
-2,6 vs self
GN
GNW—
Genworth Financial Inc
$9,82
3,9B USDP/E
16,5x
+15,1 vs self
Div yield
—
— vs self
ROE
2,5 %
-1,6 vs self
JX
JXN—
Jackson Financial Inc
—
—P/E
—
— vs self
Div yield
—
— vs self
ROE
—
— vs self
AX
AXS—
AXS
$105,90
8,0B USDP/E
7,3x
+5,9 vs self
Div yield
1,8 %
— vs self
ROE
15,8 %
+11,7 vs self
Market position
Stress test
— missing data
Predictor forecast
Next quarternear-term
Earnings · next quarterconf 45 %
EPS
Consensus EPS
0,99
Predicted surprise
+0,00
Beat probability
45 %
Analysts
5
Other metrics
Revenue
—
no estimate
Segment revenue
—
no estimate
Margin
—
no estimate
Segment margin
—
no estimate
as of 2026-05-16 · Earnings Surprise V1
Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
Full fiscal year~1 year ahead
Full fiscal year · our forecast vs guidance vs consensus
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 0,99 |
| Revenue | —no estimate | —no estimate | 427,7M USD |
| Operating income | —no estimate | —no estimate | 49,2M USD |
Full-year consensus mean (period as reported by source) · consensus in USD. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
Probabilistic model output — not investment advice. · generated 2026-08-04
Options
— missing data
Short squeeze
— missing data
Earnings-call key lines
— missing data
Consensus distribution
sell-side coverageRecommendation distribution5 analysts
Strong buy0
Buy0
Hold5
Sell0
Strong sell0
12-month price target$2,25 · Median $2,00
Low $2,00High $3,00
Operating income · consensus49,2M USD
EPS surprise
−77,9 %
reported vs consensus · miss
Revenue surprise
+29,5 %
reported vs consensus · beat
Estimate revisions
consensus EPS · 26-week trend— missing data
Sell-side observations
Low$2,00
Mean$2,25
Median$2,00
High$3,00
Spot$1,41
+59.6 %implied to mean12-month sell-side price targets · ▲ spot
Themes
— missing data
ESG
— missing data
Risk factors
Dilution riskLow
Liquidity riskMedium
Filing-based flags
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Op Margin12,0 %Below median
Net Margin7,2 %Above median
ROE4,1 %Below median
Capex / Rev-2,8 %Below median
D/E0,12Below median
Cash Conv-0,63Bottom quartile
Corporate actions / M&A
— missing data
FX exposure
— missing data
Comparable transactions
— missing data
Derivatives & instruments
— missing data
Actions
Ask Handelsavisen
— missing data
Data sources
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
How metrics are computed
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
Source documents
- eHealth Inc Market data — financials · 2026-05-27
- eHealth Inc Market data — analyst estimates · 2026-05-27
- eHealth Inc Market data — ESG · 2026-05-27
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,00 %$2M
- Investment Managers · as of 2026-03-310,00 %$1M
- Institutional Investor · as of 2022-09-300,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2024-06-300,00 %$5M
- Investment Managers · as of 2025-12-310,00 %$7M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Funds · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
Insider activity
Net buying2 buys · 0 sellsnet $298K11 insiders · last 365d
- Director · Common StockOther 61 041 · 2026-06-18
- Director · Common StockOther 61 041 · 2026-06-18
- Director · Common StockOther 61 041 · 2026-06-18
- Director · Common StockOther 61 041 · 2026-06-18
- Director · Common StockOther 61 041 · 2026-06-18
- Director · Common StockOther 61 041 · 2026-06-18
- Director · Common StockOther 61 041 · 2026-06-18
- SVP, General Counsel & Secr. · Common StockOther 1 782 @ $1,64$3K · 2026-06-10
- Chief Revenue Officer · Common StockOther 4 311 @ $1,64$7K · 2026-06-10
- Chief Financial Officer · Common StockOther 1 500 @ $1,89$3K · 2026-05-10
- Chief Financial Officer · Common StockOther 4 206 @ $1,89$8K · 2026-04-24
- Chief Revenue Officer · Common StockOther 3 571 @ $1,89$7K · 2026-04-24
- SVP, General Counsel & Secr. · Common StockOther 3 588 @ $1,89$7K · 2026-04-24
- Chief Financial Officer · Common StockOther 2 809 @ $1,32$4K · 2026-04-10
- SVP, General Counsel & Secr. · Common StockOther 7 451 @ $1,32$10K · 2026-04-10
- Chief Revenue Officer · Common StockOther 323 @ $1,32$426 · 2026-04-10
- Chief Financial Officer · Common StockOther 73 500 · 2026-03-18
- SVP, General Counsel & Secr. · Common StockOther 59 500 · 2026-03-18
- Chief Revenue Officer · Common StockOther 70 000 · 2026-03-18
- Director · Common StockOther 250 000 · 2026-03-18
- SVP, General Counsel & Secr. · Common StockOther 2 045 @ $1,62$3K · 2026-03-10
- Chief Revenue Officer · Common StockOther 5 058 @ $1,62$8K · 2026-03-10
- Chief Financial Officer · Common StockBought 25 000 @ $1,53$38K · 2026-03-06
- Director, Chief Executive Officer · Common StockBought 187 969 @ $1,38$259K · 2026-02-27
- Chief Financial Officer · Common StockOther 1 738 @ $1,98$3K · 2026-02-10
Short positioning
774.2Kshares short+8.8% vs prior
2.01days to cover
33.8%short of daily vol
1.1Kfails-to-deliver
as of 2026-07-15 · short-interest report (free)
Geographic breakdown
— missing data
Listings · one canonical issuer
all listings resolve to the canonical
EHTH.OCanonical
NASDAQ · USD
Intel & risk
peak dispatch · —
OSINT findings
Dilution riskLow
Liquidity riskMedium
Net cash is negative after subtracting total debt.
Relationship graph
This companySectorSubsidiaries
Evidence & claims
From filings & derived data- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 25.9%Derived (calculated)
- Current ratio (FY 2025-12-31): 3.37xDerived (calculated)
- Debt-to-equity (FY 2025-12-31): 0.49xDerived (calculated)
- Capex (YoY) (2025-12-31 vs 2024-12-31): 7.4%Derived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 88.1%Derived (calculated)
- Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): -25.7%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 71.4%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 71.4%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): 296.0%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -38.0%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): 182.1%Derived (calculated)
- R&D expense (YoY) (2025-12-31 vs 2024-12-31): 11.3%Derived (calculated)
- Revenue (YoY) (2025-12-31 vs 2024-12-31): 4.1%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 0.5%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): 9.3%Derived (calculated)
- Long-term debt (YoY) (2025-12-31 vs 2024-12-31): 65.0%Derived (calculated)
- Gross profit (YoY) (2025-12-31 vs 2024-12-31): 15.5%Derived (calculated)
- Return on assets (FY 2025-12-31): 3.2%Derived (calculated)
- Return on equity (FY 2025-12-31): 6.8%Derived (calculated)
- Gross margin (FY 2025-12-31): 43.5%Derived (calculated)
- Net margin (FY 2025-12-31): 7.2%Derived (calculated)
- R&D expense (annual): USD 13.8MSEC XBRL filing
- Gross profit (annual): USD 240.77MSEC XBRL filing
- Operating income (annual): USD 66.49MSEC XBRL filing
Showing 24 of 60 surfaced claims.
Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.
The Thread
Everything we know, in order2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
2026-06-18 00:00 UTCINSIDER9 insider transactions — 2026-06
2026-06-18INSIDERArden Todd transacted 61.0k sh — Director
2026-06-18INSIDERBrooke Beth A. transacted 61.0k sh — Director
2026-06-18INSIDERHass A John transacted 61.0k sh — Director
2026-06-18INSIDERBhatt Prama transacted 61.0k sh — Director
2026-06-18INSIDERWOLF DALE B transacted 61.0k sh — Director
2026-06-18INSIDERSOISTMAN FRANCIS S JR transacted 61.0k sh — Director
2026-06-18INSIDERRussell Erin L transacted 61.0k sh — Director
2026-06-10INSIDERGalimi Gavin G. transacted 1.8k sh — SVP, General Counsel & Secr. ~$3k
2026-06-10INSIDERBarbeau Michelle Marie transacted 4.3k sh — Chief Revenue Officer ~$7k
2026-05-10 00:00 UTCINSIDER1 insider transaction — 2026-05
2026-05-10INSIDERDolan John Joseph transacted 1.5k sh — Chief Financial Officer ~$3k
2026-04-24 00:00 UTCINSIDER6 insider transactions — 2026-04
2026-04-24INSIDERDolan John Joseph transacted 4.2k sh — Chief Financial Officer ~$8k
2026-04-24INSIDERBarbeau Michelle Marie transacted 3.6k sh — Chief Revenue Officer ~$7k
2026-04-24INSIDERGalimi Gavin G. transacted 3.6k sh — SVP, General Counsel & Secr. ~$7k
2026-04-10INSIDERDolan John Joseph transacted 2.8k sh — Chief Financial Officer ~$4k
2026-04-10INSIDERGalimi Gavin G. transacted 7.5k sh — SVP, General Counsel & Secr. ~$10k
2026-04-10INSIDERBarbeau Michelle Marie transacted 323 sh — Chief Revenue Officer ~$0k
2026-03-18 00:00 UTCINSIDER7 insider transactions — 2026-03
2026-03-18INSIDERDolan John Joseph transacted 73.5k sh — Chief Financial Officer
2026-03-18INSIDERGalimi Gavin G. transacted 59.5k sh — SVP, General Counsel & Secr.
2026-03-18INSIDERBarbeau Michelle Marie transacted 70.0k sh — Chief Revenue Officer
2026-03-18INSIDERSOISTMAN FRANCIS S JR transacted 250.0k sh — Director
2026-03-10INSIDERGalimi Gavin G. transacted 2.0k sh — SVP, General Counsel & Secr. ~$3k
2026-03-10INSIDERBarbeau Michelle Marie transacted 5.1k sh — Chief Revenue Officer ~$8k
2026-03-06INSIDERDolan John Joseph bought 25.0k sh — Chief Financial Officer ~$38k
2026-02-27 00:00 UTCINSIDER2 insider transactions — 2026-02 · net buy $256k
Showing the 40 most recent of 50 entries.
The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04
Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data
Premium coverage